were analyzed in different laboratories. This fact was dis-(8%) of ALL samples. In AML patients a significant association cussed again at an international workshop upon this issue, of CD34 expression and P-170 activity was observed (P Ͻ 0.02).
Introduction

Patients
Resistance to cytotoxic drugs is one of the major obstacles in the treatment of hematological malignancies. Different types of drug resistance have been identified. One of these is the Twenty-nine consecutive patients with newly diagnosed acute so-called multidrug resistance (MDR), characterized by the leukemia were studied, 17 of them suffering from acute overexpression of P-glycoprotein (P-170), 1, 2 encoded by the myeloid leukemia (AML) and 12 from acute lymphoblastic MDR1 gene, and/or the overexpression of multidrug resistleukemia (ALL). The diagnosis was based on cytological and ance-associated protein (MRP). 3 As we know today, both of cytochemical examination of bone marrow smears according them are transmembrane proteins that function as energyto the French-American-British (FAB) criteria. 17 Surface markdependent pumps, decreasing the intracellular drug conceners were analyzed with a panel of T, B and myeloid lineagetrations. 3, 4 This process is not specific for one single substance associated monoclonal antibodies (MoAbs). The AML at all, but tumor cells showing the MDR phenotype are resistpatients' age ranged from 26 to 80 years, with a median of ant against a wide range of apparently, in structure and mech-54 years and the ALL patient's age ranged from 1 to 64 years anism of toxicity, unrelated anticancer drugs. Meanwhile with a median of 23 years. FAB classification of AML revealed: there also exists clear data about the clinical significance of four M1, five M2, two M4, six M5. The immunophenotypes MDR, [5] [6] [7] and a number of MDR modulator trials have been of ALL were: nine common-ALL, three T-ALL. Patients' initiated to estimate the value of adding them to the regular characteristics and results are summarized in Table 1 . treatment protocols for the reversal of clinical resistance. 8, 9 Samples from bone marrow or peripheral blood were collected in 10 ml tubes containing heparin as anticoagulant. Mononuclear cells were separated by density gradient centrifugation (Lymphoprep; Nycomed, Oslo, Norway) and washed for RT-PCR were frozen immediately in liquid nitrogen. Rh123 efflux assay and flow cytometric analysis by mean channel fluorescence intensities instead of percentage positive cells gave comparable results. Data were processed with a Consort 30 software (Becton Dickinson). All The assay and analysis were performed as described before. 16, 18 Aliquots of 500 l cell suspension (1 × 10 6 cells) flow cytometric studies were carried out in duplicate. were incubated for 45 min at room temperature simultaneously with 150 ng/ml Rh123 and with phycoerythrin (PE)-labeled MoAbs (CD33/CD13/CD15/CD14 for AML; CD1/CD3/CD7/CD10/CD19 for ALL and CD34 for both entities). After two washes in ice-cold medium, cells were Cytospin preparations and immunocytochemistry resuspended in Rh123-free medium containing either an MDR inhibitor (10 mol/l verapamil) or no MDR inhibitor. The Rh123 efflux was selectively determined for the PE-labeled Cells were suspended in PBS and centrifuged on object-slides, air dried for at least 2 h (maximum 24 h), then fixed in acetone cells after 1 h and 2 h. Between measurements cells were kept at 37°C.
for 5 min and afterwards frozen at −80°C. For immunocytochemical staining the slides were incubated with 50 l of diluted Stained cells were analyzed on a FACStar flow cytometer (Becton Dickinson, Mountain View, CA, USA) equipped with MoAbs JSB1, directed against an internal epitope, and MM4.17, directed against an external epitope of P-170, or isoa 5 W argon-ion laser emitting at 488 nm with 250 mW power. Rh123 fluorescence was collected through a type-matched controls for 18 h at 4°C. After three washes in Tris buffer, peroxidase-conjugated anti-mouse (rabbit) and 530/30 nm and PE fluorescence through a 585/40 nm bandpass filter. Dual fluorescence studies were performed as swine anti-rabbit Ig were added for 30 min at 20°C (dilution 1:10) and after washing, the slides were incubated with diamidescribed before. To determine the fraction of cells showing Rh123 efflux a marker was set to the left of the fluorescence nobenzidine tetrahydrochloride (DAB) for 10 min at 20°C and washed three times. Cells were counter-stained with Mayer's peak of cells, which were coincubated with MDR inhibitors. Samples were scored positive when, without MDR modulator, hemalum solution. The MDR cell line KB-8-5 was used as a positive control, the cell line KB-3-1 as a negative control a clear subpopulation of cells left of the marker was detectable after a 60 or 120 min incubation. Earlier studies using cell (both provided by Dr M Gottesmann, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA). lines showed that the percentage of the P-170 negative KB-3-1 cells showing Rh123 efflux was always below 10% (range Stained slides were analyzed for percentage of positive cells (0-25%, 26-50%, 51-75%, 76-100%) and for staining inten-0-8%) whereas the percentage of P-170 expressing KB-8-5 cells was always clearly above 10%. Interpretation of results sity (+, ++. +++) by two independent investigators.
Detection of MDR1 and MRP-mRNA levels by pumping activity (P Ͻ 0.007 when compared with the remaining FAB subtypes). For both groups (AML + ALL) there was no RT-PCR association between Rh123 efflux and leukocyte or thrombocyte count, hemoglobin level, blast infiltration of the bone Total RNA was isolated using RNAzol (Biotexs Laboratories, Houston, TX, USA) as described by the manufacturer. cDNA marrow or lactate dehydrogenase level. was synthesized with 500 ng of total cellular RNA and 5 pmol/l hexanucleotide random primers (Boehringer Mannheim, Germany) at 37°C in a volume of 50 l, containImmunocytochemistry = protein level ing 50 mM Tris-HCl, pH 8.3, 50 mM KCl, 8 mM MgCl 2 , 100 g/ml bovine serum albumin, 20 mM ␤-mercaptoethanol, Twenty-five cytospin preparations were examined for staining 1 mM each of deoxynucleotide, 1.25 units RNasin (Promega, with the monoclonal antibody JSB1, specific for a cytoMadison, WI, USA) and 120 units MMLV reverse transcriptase plasmatic domain of P-170. Among these 25 cases there were (Promega). Amplification of MDR1 and MRP was carried out 16 AML and nine ALL. Eight of 25 revealed positive results, by polymerase chain reaction using 2 l cDNA representing 32%. In AML eight of 16 cases showed positive (corresponding to 5 ng of total RNA) in a volume of 50 l, staining (50%), while in ALL none of the nine cases was containing 10 mM Tris-HCl, pH 9.0, 50 mM KCl, 1.5 mM scored positive. In all the positive AML cases staining was MgCl 2 , 0.1% Triton X-100, 0.2 mM deoxynucleotides each weak, with a cytoplasmatic pattern (characteristic for transand 3 units Taq-polymerase (Promega). ␤ 2 -microglobulin was membrane proteins on cytospin preparations) and the percentused as a control for employing similar amounts of RNA in age of positive cells exceeded at least 50%. the experiment. The following primers were used (Microsynth,
The second monoclonal antibody used in our study, Balgach, Switzerland): MDR1 (product length 157 base pairs):
MM4.17, which is directed against an external epitope of P-5Ј CCC ATC ATT GCA ATA GCA GG 3Ј (sense) and 5Ј GTT 170, was applied to the tumor specimens of 24 patients (16 CAA ACT TCT GCT CCT GA 3Ј (antisense); 19 MRP (product AML and eight ALL). Eighteen of 24 were scored positive for length 296 base pairs): 5Ј GGA AAC CAT CCA CGA CCC this antibody (75%), with 14 AML (87%) and four ALL (50%). TAA TCC CT 3Ј (sense) and 5Ј CCA CCT CCT CAT TCG CAT Although the staining was quite strong, the pattern was not CCA CCT TG 3Ј (antisense); B 2 -mg (product length 120 base that clear cytoplasmatically, and in some cases an apparently pairs): 5ЈACC CCC ACT GAA AAA GAT GA 3Ј (sense) and 5Ј nonspecific staining of the nuclei occurred. The percentage of ATC TTC AAA CCT CCA TGA TG 3Ј (antisense). 19 Thirty MM4.17-positive cells thereby always exceeded at least 25%. cycles were performed, with a denaturation temperature of An agreement between the two monoclonal antibodies was 94°C for 25 s, an annealing temperature of 57°C for 30 s and observed in only 13/23 (57%) patients where both tests an extension temperature of 73°C for 1 min. Following cycle were performed. 16 the time for synthesis at 73°C was extended for 5 s per cycle. The reaction products were separated on a 10% polyacrylamide gel (BioRad, Hercules, CA, USA) and stained with RT-PCR = genetic level ethidium bromide. Intensity of the DNA bands was determined by densitometry (Vilber-Lourmat, Marne La Vallée, The leukemic blasts of 12 patients have also been examined France). mRNA levels were quantified as ratio MDR1/␤ 2 -mg by RT-PCR, searching for the respective levels of MDR1-and and MRP/␤ 2 -mg, respectively. 20 The following cell lines MRP-mRNA. An increased level of MDR1 was found in 4/12 served as controls: parental KB-3-1 and resistant KB-8-5 for cases (33.3%) and for MRP in 3/12 cases (25%). For MDR1 MDR1 mRNA expression and parental HL-60 and resistant in AML four of seven cases were positive, the levels of mRNA HL-60/AR for MRP mRNA expression (provided by Dr being 1.36/0.99/0.24/0.36 (ratio MDR1/␤ 2 -mg). The resistant Gekeler, Byh Gulder, Konstanz, Germany).
cell line KB-8-5 was used as a positive control with a MDR1/␤ 2 -mg ratio of 1.08. All five ALL cases were negative. The three cases with elevated MRP-mRNA levels also Results belonged to the group of AML exclusively. Their levels were also correlated to (mean 48%) for AML, and was 15% in the single positive ALL. These data are in good accordance with earlier studies. 21 Examples for Comparing the flow cytometric Rh123 assay with immunocytochemistry we observed a very good correlation between positive and negative assays are shown in Figure 1 .
In AML we found a statistically significant correlation MoAb JSB1 (P Ͻ 0.004), but not MM4.17 (NS). This trend also continued when looking at the PCR results, measuring MDR1-between Rh123 efflux and the blasts expressing CD34 (P Ͻ 0.03). On the other hand, analysis revealed an inverse corremRNA. The correlation to JSB1 was quite good (P Ͻ 0.05), compared with MM4.17 (NS). Neither antibody showed a lation between a positive functional Rh123 assay and the expression of the CD15 surface marker by the AML blasts (P Ͻ significant correlation with MRP-mRNA expression. Association of the results of the functional assay and PCR 0.008). All the other markers examined in AML (CD33, CD13, CD14, CD7), did not show significant correlation.
analysis was high for Rh123/MDR1 (r = 0.819, P Ͻ 0.001; Figure 3a ) and low for Rh123/MRP (r = 0.562, NS; Figure 3b ). As far as FAB classification was concerned, none of the six monocytoid differentiated AML cases (M5) showed Rh123
The results of all three methods used did not correlate with One patient (No. 26) showed a rapid pumping activity of One of the major investigational issues concerning chemoresistance is to establish the best combination of methods for 50% of the leukemic blasts, but lacked MDR1 and MRP mRNA expression. Another interesting observation was made the detection of the MDR phenotype in clinical samples. In the study presented here, we tried to compare three different with patient No. 18 whose blast cells showed a high level of MRP mRNA but no pumping activity in the functional assay.
MDR screening techniques in 29 patients suffering from acute currently published studies. 21, 22 Co-staining of Rh123 with specific surface markers enables the discrimination of blast cells from normal blood cells. Thus, this assay meets the criterium of specificity. Additionally, even low levels of drug resistance are detectable by measuring Rh123 efflux including cells with only 1.7-fold increase in resistance. 23 Furthermore, this method offers the possibility of checking the state of activity for monitoring the MDR1 phenotype in leukemias, in a recently published study. 24 An important issue of our study was to gain information as to whether the Rh123 assay is also able to recognize the function of MRP, as inconsistent data exist, whether Rh123 is one of its substrates or not. 25 Interestingly, we found that the pumping out of Rh123 did not always take the same length of time. In four of our samples we found slow pumping activity that lasted continuously for 2 h and more, while usually after an interval of 1 h the fluorescence patterns did not change further. We presumed that transport mechanisms different from P-170, like MRP, might be responsible for this phenomenon. However, our study did not reveal any significant correlation between the results of Rh123 assay and PCR for MRP-mRNA (P Ͻ 0.48).
Immunocytochemistry also offers the possibility of single cell analysis, and meanwhile there exists a great panel of monoclonal antibodies specific for P-170. As previously demanded by different investigators, 11, 24 we used two of these antibodies directed against different epitopes, JSB1 and MM4.17, in our study. The cytospin preparations stained with JSB1 were easy to interpret, although the staining in the positive cases was quite weak (+). However, we observed a good correlation of this method with the functional test (P Ͻ 0.004).
As far as MM4.17 is concerned, the situation was much more difficult. The staining was considerably stronger, but it did not always seem to be limited to the plasma membrane and unspecific staining of the nuclei was hard to exclude. This fact also led to considerable disagreement in the interpretation of results by two independent investigators. Furthermore, there was no correlation between MM4.17 staining and Rh123 efflux. From this point of view we do not consider this antibody to be of value for the detection of P-170 on cytospin preparations, although our group has experienced better results applying this antibody to cryostat sections. 21 The reason for this discrepancy is not clear at present.
Finally, we also performed a RT-PCR as a third method. One major problem concerning this technique was to prevent mRNA from immediate degradation, as our clinical samples were also processed for routine diagnosis. Thus, mRNA was extractable only from 12 patients' samples. This issue may limit the use of RT-PCR for routine assessment of MDR in clinical samples. However, comparing RT-PCR with the other use of a functional flow cytometric assay with Rh123 and a immunocytochemical staining of acetone-fixed cytospin preparations with the monoclonal antibody JSB1, as performed in leukemia, and examined how far they meet the criteria demanded above (see Introduction).
our study, as a reliable and practical approach to determine P-170 expression in clinical samples. The combination of both Using flow cytometry, we performed a functional assay, with the fluorescent dye Rh123 acting as a substrate of P-170.
methods not only fulfills the criteria mentioned above, but also sufficiently corresponds with the recommendations We observed Rh123 efflux in 9/17 (53%) AML cases. In ALL the frequency of P-170 function was much lower with 1/12 demanded by a recent workshop on this issue: 11 use of standardized MDR cell lines as positive controls to calibrate the (8%) positive cases. These results are in good accordance with
